Ross Mangum
Overview
Explore the profile of Ross Mangum including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
60
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sheikh S, Recinos V, Thompson E, Mangum R, Wright-Nadkarni M, Gampel B, et al.
Front Oncol
. 2025 Jan;
14:1504440.
PMID: 39763605
Pediatric diffuse midline glioma (DMG), including diffuse intrinsic pontine glioma (DIPG), are aggressive brainstem tumors with a dire prognosis, traditionally diagnosed based on MRI characteristics. The recognition that molecular characteristics...
2.
Sheikh S, Klesse L, Mangum R, Bui A, Siegel B, Abdelbaki M, et al.
Front Oncol
. 2025 Jan;
14:1503894.
PMID: 39759151
Pediatric low-grade gliomas (pLGGs) are the most common brain tumors in children. Many patients with unresectable tumors experience recurrence or long-term sequelae from standard chemotherapeutics. This mini-review explores the emerging...
3.
Judd D, Almefty K, Vern-Gross T, Hoffman L, Abdullaev Z, Quezado M, et al.
J Pediatr Hematol Oncol
. 2024 Nov;
47(1):e52-e57.
PMID: 39589148
Atypical teratoid/rhabdoid tumor (ATRT) is an aggressive, malignant embryonal tumor with dismal long-term survival despite aggressive multimodal therapy. While this tumor typically presents in infancy or early childhood, there are...
4.
George A, Conneely S, Mangum R, Fasipe T, Lupo P, Scheurer M
Pediatr Blood Cancer
. 2024 Jul;
71(10):e31219.
PMID: 39054677
Objective: To delineate the natural history of splenic complications other than loss of splenic function in children with sickle cell disease (SCD), we performed a retrospective chart review of patients...
5.
Mangum R, Lin F, Parsons D
J Pediatr Hematol Oncol
. 2024 Jun;
46(5):262-271.
PMID: 38857189
Precision oncology incorporates comprehensive genomic profiling into the individualized clinical care of pediatric cancer patients. In recent years, comprehensive pan-cancer analyses have led to the successful implementation of genomics-based pediatric...
6.
Retson L, Tiwari N, Vaughn J, Bernes S, Adelson P, Mansfield K, et al.
Mol Ther
. 2023 Aug;
31(10):2991-2998.
PMID: 37598295
Spinal muscular atrophy is an autosomal recessive disease resulting in motor neuron degeneration and progressive life-limiting motor deficits when untreated. Onasemnogene abeparvovec is an adeno-associated virus serotype 9-based gene therapy...
7.
Mangum R, Reuther J, Sen Baksi K, Gandhi I, Zabriskie R, Recinos A, et al.
Pediatr Hematol Oncol
. 2023 Jun;
40(8):719-738.
PMID: 37366551
The potential of circulating tumor DNA (ctDNA) analysis to serve as a real-time "liquid biopsy" for children with central nervous system (CNS) and non-CNS solid tumors remains to be fully...
8.
Severseike B, Schafernak K, Willard S, Goncalves L, Kothari A, Eshun F, et al.
J Clin Lab Anal
. 2023 Feb;
37(4):e24854.
PMID: 36843202
Background: Renal medullary carcinoma (RMC) is a diagnostically challenging, aggressive primary renal malignancy associated with abysmal survival. Delays in diagnosis contribute to most patients having diffusely metastatic disease at the...
9.
Hoffman L, Jaimes C, Mankad K, Mirsky D, Tamrazi B, Tinkle C, et al.
Neuro Oncol
. 2022 Sep;
25(2):224-233.
PMID: 36124689
Background: Craniopharyngioma is a histologically benign tumor of the suprasellar region for which survival is excellent but quality of life is often poor secondary to functional deficits from tumor and...
10.
Goode E, Montoya L, Graham E, Pruniski B, Simmons C, Ngwube A, et al.
JCO Precis Oncol
. 2022 Mar;
6:e2100403.
PMID: 35357904
No abstract available.